Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Ewing Sarcoma Breakpoint Region 1 (EWSR1) (Middle Region) Peptide

EWSR1 Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN5671566

Quick Overview for Ewing Sarcoma Breakpoint Region 1 (EWSR1) (Middle Region) Peptide (ABIN5671566)

Target

EWSR1 (Ewing Sarcoma Breakpoint Region 1 (EWSR1))

Origin

Human

Source

  • 10
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Sequence

    QSSFRQDHPS SMGVYGQESG GFSGPGENRS MSGPDNRGRG RGGFDRGGMS

    Characteristics

    This is a synthetic peptide designed for use in combination with anti- EWSR1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    EWSR1 (Ewing Sarcoma Breakpoint Region 1 (EWSR1))

    Background

    This gene encodes a multifunctional protein that is involved in various cellular processes, including gene expression, cell signaling, and RNA processing and transport. The protein includes an N-terminal transcriptional activation domain and a C-terminal RNA-binding domain. Chromosomal translocations between this gene and various genes encoding transcription factors result in the production of chimeric proteins that are involved in tumorigenesis. These chimeric proteins usually consist of the N-terminal transcriptional activation domain of this protein fused to the C-terminal DNA-binding domain of the transcription factor protein. Mutations in this gene, specifically a t(11,22)(q24,q12) translocation, are known to cause Ewing sarcoma as well as neuroectodermal and various other tumors. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 1 and 14.

    Alias Symbols: EWS, EWS-FLI1, bK984G1.4

    Protein Size: 354

    Gene ID

    2130

    NCBI Accession

    NM_001163285, NP_001156757
You are here:
Chat with us!